What is BIAF stock price today?

Visit our real-time dashboard for the current BIAF stock price and live market data.

Is BIAF stock going up or down today?

BIAF stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy BIAF stock now?

The decision to buy BIAF depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is BIAF a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for BIAF based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is BIAF stock overvalued or undervalued?

Use our DCF valuation calculator to determine if BIAF is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is BIAF's P/E ratio?

P/E ratio data for BIAF will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is BIAF's market cap?

BIAF (bioAffinity Technologies, Inc.) has a market capitalization of $0.00 billion, making it a small-cap stock.

What is BIAF's price to book ratio?

Price-to-book ratio for BIAF is available on our dashboard along with other valuation metrics.

Does BIAF pay dividends?

BIAF does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is BIAF's dividend yield?

BIAF does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is BIAF stock a good long-term investment?

BIAF's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is BIAF's revenue growth rate?

Revenue growth data for BIAF is available on our dashboard with detailed financial statement analysis.

Profitability metrics for BIAF are available on our dashboard with complete income statement analysis.

What are the risks of investing in BIAF?

Key risks for BIAF include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does BIAF compare to its competitors?

Compare BIAF to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize BIAF's performance and positioning.

What is BIAF's stock price target for 2026?

Visit our prediction page for AI-powered price targets for BIAF with bull, base, and bear case scenarios.

What do analysts say about BIAF?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for BIAF. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is BIAF's next earnings report?

BIAF reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

BIAF - bioAffinity Technologies, Inc.

NYSE * Healthcare * Diagnostics & Research

$0.00

+$0.00 (+0.00%)

About bioAffinity Technologies, Inc.

bioAffinity Technologies, Inc. (BIAF) common stock

Price Chart

Loading chart...

BIAF Key Statistics

Market Cap

$3.95M

How BIAF Compares to Peers

BIAF is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
BIAF(This stock)	$3.95M	N/A	0%	0.0%	-
UNHUnitedHealth Group	$362.83B	30.1	0%	0.0%	vs UNH
JNJJohnson &	$375.37B	17.4	0%	0.0%	vs JNJ
LLYEli Lilly	$991.62B	39.5	0%	0.0%	vs LLY
PFEPfizer Inc	$147.73B	19.8	0%	0.0%	vs PFE
ABBVAbbVie Inc	$334.34B	80.5	0%	0.0%	vs ABBV

Data Updated: July 23, 2026 at 6:06 PM EDT

Ready to invest in BIAF?

Commission-free trading available. Affiliate links.

Upcoming Events for BIAF

Dashboard

Enter a ticker to analyze